AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Armata Pharmaceuticals, Inc. Director's Dealing 2009

May 19, 2009

34152_dirs_2009-05-19_6e329928-c93e-401f-bfb1-896c3a093508.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2009-05-15

Reporting Person: Robinson BG Susan (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-05-15	Common Stock	F	3809	$0.21	Disposed	63106	Direct
2009-05-17	Common Stock	F	3809	$0.21	Disposed	59297	Direct

Footnotes

F1: On May 15, 2009, 11,667 restricted shares of common stock vested for the reporting person and the reporting person surrendered 3,809 of such shares to the Company as payment for the withholding taxes due in connection with such vesting.

F2: On May 17, 2009, 11,667 restricted shares of common stock vested for the reporting person and the reporting person surrendered 3,809 of such shares to the Company as payment for the withholding taxes due in connection with such vesting.